Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy
about
Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathyPeroxisome Proliferator-Activated Receptor- γ in Thyroid AutoimmunityRole of Peroxisome Proliferator-Activated Receptor γ in Ocular DiseasesCurrent concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.TSH Receptor Signaling Abrogation by a Novel Small MoleculeImaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathyThiazolidinedione induced thyroid associated orbitopathyPingmu Decoction Induces Orbital Preadipocytes Apoptosis In VitroA stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments.Insights into the role of fibroblasts in human autoimmune diseases.Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatmentSusceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related InflammationTSH stimulates adipogenesis in mouse embryonic stem cellsImmune mechanisms in thyroid eye disease.Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.A modified ELISA accurately measures secretion of high molecular weight hyaluronan (HA) by Graves' disease orbital cells.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.Radiotherapy for Graves' disease. The possible role of low-dose radiotherapyAdiponectin concentration in the orbital fat of patients with Graves' ophthalmopathyThalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease.Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy.Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
P2860
Q24301803-FDF0B3F4-CA60-4519-88E4-659D2AEA0AC6Q27012610-2E106FD4-702A-4E74-8941-6756FDFC575BQ27022369-6FCB7911-515C-49B6-A05B-06DA2B030FD7Q27022548-73572542-1C83-4EB6-9825-0262A29DAC42Q27691806-024669E4-29CA-4353-850B-581F608711BFQ28828962-78BE9E3B-E7B3-4939-9949-F68F381F6F69Q30461261-CE304867-9360-4DC6-8003-3ADC478D7229Q33282924-860D7EEB-ACBC-4C2D-AAFC-6B14AC5B0B8FQ33623928-A161EB46-1758-4C31-85D2-6CC90661CCFAQ33707825-E5533DA4-AFC1-4528-A185-067E9B2ADF2BQ33801404-A1344A32-0500-4F5A-B47B-B1A9F1193A08Q34782210-1B2C9255-235E-4CC0-B901-FC720D6B8B53Q35154018-1DC051A4-67E5-4CF5-97F2-F7D8758CBD06Q36208013-CD043363-2893-4076-845D-A375D7B926B0Q36525240-0FE63FF9-C247-41E1-85CA-C1BFDF95CF5FQ36830207-AB843ABC-5561-4DEF-BEF1-F98D799AA83AQ36970632-1F987892-065E-4D9F-898A-BFDAF3879146Q37114625-848DC48B-D390-49F8-871E-2DF8227FC12BQ37218305-C4E94A5B-3CCC-44D9-B703-ACFD3ACC859EQ37254482-941FB43E-E013-451C-82FE-319596B0BD4EQ37404274-C5BD3E03-AABF-4049-9764-4912CB9D8F2CQ37479329-9DF8A904-BFD3-4A50-93D7-DE194B9A2A1EQ38633022-3B7CD485-AC2F-4DF8-9A7B-544312F41E00Q38948145-592B3CD8-CFBA-4F81-961C-F99CB6FCE25EQ42132464-1ADC06E7-44AC-453A-B15F-AFA9B830E4BEQ42801091-C1C97110-DB2B-4141-859B-E1430C1E3DA7Q45115361-7802B0EC-96A3-42D7-898A-6FCE42A8EBD2Q46255536-868174FD-EEE1-4E60-9BDD-F4599F46AE54Q47121440-A63D02F5-01CC-47EC-88D2-DF5B4669D31CQ50665936-A2D7EF3B-A39B-499B-B6D1-4AE4247B31AA
P2860
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy
@en
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
@nl
type
label
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy
@en
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
@nl
prefLabel
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy
@en
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
@nl
P2093
P2860
P356
P1476
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy
@en
P2093
Michael J Coenen
Philipp E Scherer
Rebecca S Bahn
Seema Kumar
P2860
P304
P356
10.1210/JC.2003-031427
P407
P577
2004-02-01T00:00:00Z